News
The first meeting of the Working Groups of the project GENERATION OF HUMAN INDUCED PLURIPOTENT STEM CELLS FROM HAPLO-SELECTED CORD BLOOD SAMPLES (HAPLO-IPS)
The project aims to create a collaborative network for induced pluripotency stem cells (iPS) homozygous for the most frequent HLA haplotypes generation.
A drug that boosts the regeneration of stem cells extends life expectancy in mice
The project aims to create a collaborative network for induced pluripotency stem cells (iPS) homozygous for the most frequent HLA haplotypes generation.
It starts a project to create a collaborative network for the generation of stem cells compatible with a high percentage of the population
The project aims to create a collaborative network for induced pluripotency stem cells (iPS) homozygous for the most frequent HLA haplotypes generation.
A study describes a new way to generate insulin-producing cells
Researchers from the Karolinska Institute in Sweden, in collaboration with Meritxell Rovira from IDIBELL, the P-CMRC, and the UB show that a recently identified molecule stimulates the formation of new insulin-producing cells in zebrafish and in mammalian tissues.
New mural in tribute to Dr. Anna Veiga
The mural is located in the CEIP Pinedo of Valencia and is a piece by the artist Marta Lapeña. This is the mural number 27 of the project with which the UPV and Las Naves are filling the Valencian educational centers with science and art, in feminine.
Begins the exchange program between IDIBELL and SZBL
It begins the selection of candidates to carry out a doctoral program in Regenerative Medicine between the SZBL and the IDIBELL. The program will run mainly at SZBL and will have a minimum six months stay at IDIBELL.
Joint SZBL-IDIBELL PhD Exchange Program (2022 Call)
SZBL and IDIBELL launch their joint PhD Exchange Program call for 2022, with the aim of fostering collaboration in research between both institutions in the field of Regenerative Medicine and providing exceptional training in the field for graduated students by promoting mobility and allowing interaction with outstanding researchers.
The generation of a stem cell-derived neurofibroma model opens the door to new treatments development
Neurofibromas are tumors of the peripheral nervous system, which develop in people with a hereditary disease, and they are the main cause of death among those people.
Nanopolymer treatment prevents the formation of protein aggregates in neurons derived from Parkinson’s patients
One of the hallmarks of Parkinson’s disease is the abnormal accumulation of the α-synuclein protein that causes neuronal death responsible for motor impairments. Dendrimers are highly branched polymers that decrease α-synuclein accumulation in dopaminergic neurons derived from patient stem cells.
Pancreatic beta-cell boost in mice paves way for future diabetes treatments
A research team from IDIBELL, CRG and UB has uncovered the role of a gene that is critical to boosting the number of insulin-producing cells during the early development of the pancreas. The findings could bolster diabetes research efforts and eventually lead to new replacement therapies for the disease.
Identified an early neuronal dysfunction in Parkinson’s that could help early diagnosis
The new Clinical Translational Program for Regenerative Medicine in Catalonia (P-CMR [C]), propelled by the Center of Regenerative Medicine in Barcelona (CMR[B])…
CRISPR/Cas9 Human Embryo Genome Editing for the Study of Genes Related to Early Embryo Development
Dr. Anna Veiga is leading the project CRISPR/Cas9 human embryo genome editing (GE) for the study of genes related to early embryo development.
P-CMR[C] researchers define a new mechanism of aging in a bone marrow stem cell in women
To equilibrate the gene expression between XX females and XY males, one of female X chromosomes is inactivated. Researchers from IDIBELL Regenerative Program has discovered that this inactivation is affected in bone marrow aged stem cells.
The group led by Dr. Alessandra Giorgetti receives a grant from the GESMD to study myelodysplastic syndrome
The new Clinical Translational Program for Regenerative Medicine in Catalonia (P-CMR [C]), propelled by the Center of Regenerative Medicine in Barcelona (CMR[B])…
The team led by Dr. M. Carolina Florian receives a European grant of 2 million euros to study bone marrow rejuvenation
The new Clinical Translational Program for Regenerative Medicine in Catalonia (P-CMR [C]), propelled by the Center of Regenerative Medicine in Barcelona (CMR[B])…
The P-CMR[C] organize an open session to present the results of the EoI Call for Collaborative Projects
We are organizing a scientific session with all the awarded projects, where all participant groups will present the research performed and the collaborations born thanks to these projects.
Jordi Guiu, the new group leader of the Regenerative Medicine Program
Jordi Guiu joins to P-CMR[C] as group leader and opens the Cell Plasticity and Regeneration group
Artificial intelligence, a new tool against leukemia
Dr. M. Carolina Florian (Program of Regenerative Medicine, IDIBELL, Spain) and Prof. Medhanie Mulaw (Ulm University, Germany) will receive more than 800.000 euros from the “La Caixa” Foundation to apply deep learning to investigate leukemia in the elderly
P-CMR[C] scientists find a compound that extends life span in mice
Regenerative medicine scientists at IDIBELL in collaboration with partners at Ulm University (Germany) have demonstrated that inhibition of Cdc42 with CASIN can pharmacologically extend lifespan.
The P-CMR[C] launches its website
The Program for advancing the Clinical Translation of Regenerative Medicine of Catalonia (P-CMR[C]), which aims to group research on stem cells in Catalonia, now has its own space in internet.
The New Program for Regenerative Medicine in Catalonia Has Officially Launched
The new Clinical Translational Program for Regenerative Medicine in Catalonia (P-CMR [C]), propelled by the Center of Regenerative Medicine in Barcelona (CMR[B])...
Read more...
IDIBELL and Dexeus Mujer will study embryonic development through human embryo genome edition
IDIBELL and Dexeus Mujer will study embryonic development through human embryo genome edition
Read more...
IDIBELL researchers Antonella Consiglio and Ángel Raya, awarded with the City of Barcelona Award
Two researchers from the Bellvitge Biomedical Research Institute (IDIBELL), have been awarded in this edition of the City of Barcelona Awards, in the Life Sciences category
Read more...
Domesticated cynomolgus monkey embryonic stem cells allow the generation of neonatal interspecies chimeric pigs
Blastocyst complementation by pluripotent stem cell
(PSC) injection is believed to be the most promising
method to generate xenogeneic organs
Read more...
The Impact of Mosaic Embryos on Procreative Liberty and Procreative Responsibility: Time to Put Innovative Technology on “Pause”
Preimplantation genetic testing for aneuploidy (PGT-A) is a controversial and an unvalidated procedure used for embryo screening and yet is being offered to patients undergoing in vitro fertilization (IVF)
Read more...
Self-Organization of Mouse Stem Cells into an Extended Potential Blastoid
Mammalian blastocysts comprise three distinct cell lineages essential for development beyond implantation: the pluripotent epiblast, which generates the future embryo...
Read more...
CRISPR-Cas3 induces broad and unidirectional genome editing in human cells
Although single-component Class 2 CRISPR systems, such as type II Cas9 or type V Cas12a (Cpf1), are widely used for genome editing in eukaryotic cells...
Read more...
High-Efficiency, Selection-free Gene Repair in Airway Stem Cells from Cystic Fibrosis Patients Rescues CFTR Function in Differentiated Epithelia
Cystic fibrosis (CF) is a monogenic disorder caused by mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene
Read more...
Circadian Entrainment Triggers Maturation of Human In Vitro Islets
Stem-cell-derived tissues could transform disease research and therapy, yet most methods generate functionally immature products
Read more...
